Telesis Bio, Inc.
NASDAQ:TBIO
0.411 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 27.509 | 27.435 | 11.043 | 6.576 | 4.805 | 1.42 | 0 | 0 |
| Cost of Revenue
| 10.559 | 11.84 | 6.744 | 2.951 | 8.889 | 0 | 0 | 0 |
| Gross Profit
| 16.95 | 15.595 | 4.299 | 3.625 | -4.084 | 1.42 | 0 | 0 |
| Gross Profit Ratio
| 0.616 | 0.568 | 0.389 | 0.551 | -0.85 | 1 | 0 | 0 |
| Reseach & Development Expenses
| 17.496 | 23.46 | 14.548 | 8.925 | 1.318 | 58.024 | 47.023 | 15.658 |
| General & Administrative Expenses
| 21.09 | 22.131 | 14.229 | 4.13 | 4.69 | 22.606 | 14.311 | 11.144 |
| Selling & Marketing Expenses
| 13.514 | 16.489 | 10.896 | 6.931 | 2.254 | 0 | 0 | 0 |
| SG&A
| 34.604 | 38.62 | 25.125 | 11.061 | 1.574 | 22.606 | 14.311 | 11.144 |
| Other Expenses
| 11.389 | -0.026 | -0.062 | -0.074 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 63.489 | 62.08 | 39.673 | 19.986 | 2.892 | 80.63 | 61.334 | 26.802 |
| Operating Income
| -46.539 | -46.485 | -35.374 | -16.361 | -6.976 | -102.96 | -78.924 | -26.698 |
| Operating Income Ratio
| -1.692 | -1.694 | -3.203 | -2.488 | -1.452 | -72.507 | 0 | 0 |
| Total Other Income Expenses Net
| -1.161 | -1.962 | -3.57 | -1.644 | -1.326 | 0 | 0 | 0 |
| Income Before Tax
| -47.7 | -48.447 | -38.944 | -18.005 | -8.302 | -102.96 | -78.924 | -26.698 |
| Income Before Tax Ratio
| -1.734 | -1.766 | -3.527 | -2.738 | -1.728 | -72.507 | 0 | 0 |
| Income Tax Expense
| 0.024 | 0.024 | 0.014 | 0.005 | -0.486 | -5.565 | -12.481 | 0.707 |
| Net Income
| -47.724 | -48.471 | -38.958 | -18.01 | -8.302 | -97.395 | -66.443 | -26.698 |
| Net Income Ratio
| -1.735 | -1.767 | -3.528 | -2.739 | -1.728 | -68.588 | 0 | 0 |
| EPS
| -1.64 | -1.65 | -1.33 | -0.62 | -0.2 | -2.16 | -2.23 | -0.89 |
| EPS Diluted
| -29.56 | -1.65 | -1.33 | -0.62 | -0.2 | -2.16 | -2.23 | -0.89 |
| EBITDA
| -40.493 | -43.617 | -36.001 | -15.495 | -6.119 | -100.119 | -77.339 | -25.968 |
| EBITDA Ratio
| -1.472 | -1.695 | -3.066 | -2.278 | -1.273 | -70.506 | 0 | 0 |